Inflammatory Markers Are Elevated in Eisenmenger Syndrome-Reference-Cited by-同舟云学术

Inflammatory Markers Are Elevated in Eisenmenger Syndrome

Published:2013-05-11 Issue:8 Volume:34 Page:1791-1796
ISSN:0172-0643
Container-title:Pediatric Cardiology
language:en
Short-container-title:Pediatr Cardiol

Author:

Ramakrishnan Sivasubramanian,Kukreti Bharat Bhooshan,Ramakrishnan Lakshmy,Salahuddin Salman,Pendharkar Amit,Karthikeyan Ganesan,Bhargava Balram,Juneja Rajnish,Seth Sandeep,Kothari Shyam S.,Saxena Anita,Bahl Vinay K.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00246-013-0715-3.pdf

Reference30 articles.

1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117

2. Beghetti M, Galiè N (2009) Eisenmenger syndrome: a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J Am Coll Cardiol 53:733–740

3. Cacoub P, Dorent R, Maistre G, Nataf P, Carayon A, Piette C, Godeau P, Cabrol C, Gandjbakhch I (1993) Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol 71:448–450

4. Caramuru LH, Lopes AA, Maeda NY, Aiello VD, Filho CC (2006) Long-term behavior of endothelial and coagulation markers in Eisenmenger syndrome. Clin Appl Thromb Hemost 12:175–183

5. Cool CD, Kennedy D, Voelkel NF, Tuder RF (1997) Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Human Pathol 28:434–442

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss;American Journal of Physiology-Lung Cellular and Molecular Physiology;2023-06-01

2. Accelerated Cardiac Aging in Patients With Congenital Heart Disease;Frontiers in Cardiovascular Medicine;2022-05-26

3. Inflammatory markers in Eisenmenger syndrome and their association with clinical outcomes. A cross-sectional comparative study;International Journal of Cardiology;2021-11

4. Congenital Heart Disease: An Immunological Perspective;Frontiers in Cardiovascular Medicine;2021-08-09

5. Altered Peripheral Blood Myeloid Cell Subpopulations in Children With Down Syndrome and Pulmonary Hypertension;Journal of Pediatric Hematology/Oncology;2017-03